| 0.5431 BATS BZX Real-Time Price As of 11:48am ET |  -0.248 / -31.35%Today’s Change | 0.48 Today|||52-Week Range 1.54 | -9.48% Year-to-Date |
| Previous close | 0.79 |
| Today’s open | 0.55 |
| Day’s range | 0.49 - 0.56 |
| Volume | 11,029,469 |
| Average volume (3 months) | 743,457 |
| Market cap | $45.8M |
| Dividend yield | -- |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +43.26% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -81.66% |
| P/E ratio | -- |
| Price/Sales | 6.60 |
| Price/Book | 2.10 |
| Today’s change | Today’s % change | |
|---|---|---|
| ABACAoxin Tianli Group I... | -0.08 | -5.19% |
| IMUCImmunoCellular Thera... | +0.00 | +0.23% |
| CASICASI Pharmaceuticals... | -0.02 | -1.20% |
| PBMDPrima BioMed Ltd | -0.02 | -2.06% |
| Next reporting date | March 24, 2015 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $6.2M |
| Annual profit (last year) | $6.8M |
| Net profit margin | -441.13% |
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer David A. Dodd |
Chief Financial Officer & Senior Vice President Dennis Turpin |
Corporate headquarters Québec, Quebec |
